U.S. Nuclear Medicine Market Size, Share, Analysis, By Type (Diagnostic Radiopharmaceuticals {PET Radiopharmaceuticals [FDG-PET/18F, 68Ga, 68Cu, 11C, and Others] and SPECT Radiopharmaceuticals [Technetium-99m, Iodine-123, Xenon-133, Thallium-201, and Others]}, and Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI109233

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 20.5% from 2024 to 2032
Unit	Value (USD Billion)
Segmentation	By Type Diagnostic Radiopharmaceuticals PET Radiopharmaceuticals FDG-PET/18F 68Ga 68Cu 11C Others SPECT Radiopharmaceuticals Technetium-99m Iodine-123 Xenon-133 Thallium-201 Others Therapeutic Radiopharmaceuticals
	By Application Neurology Cardiology Oncology Others
	By End-user Hospitals & Clinics Diagnostic Centers Others